PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31888388-0	2021	Design and synthesis of VEGFR-2 inhibitors based on oleanolic acid moiety.	Oleanolic Acid	52-66	kinase insert domain receptor	Homo sapiens	24-31	
35369968-0	2022	Design and semisynthesis of oleanolic acid derivatives as VEGF inhibitors: Inhibition of VEGF-induced proliferation, angiogenesis, and VEGFR2 activation in HUVECs.	Oleanolic Acid	28-42	kinase insert domain receptor	Homo sapiens	135-141	
35369968-2	2022	Recent studies have revealed that oleanolic acid (OA), a natural pentacyclic triterpenoid, inhibited the VEGF/VEGFR2 signaling pathway and angiogenesis in HUVECs, which may represent an attractive VEGF inhibitor.	Oleanolic Acid	34-48	kinase insert domain receptor	Homo sapiens	110-116	
31888388-1	2021	In this study, twenty-four oleanolic acid (OA) derivatives were rationally designed based on molecule docking studies and their VEGFR-2 inhibitory activities were tested by Homogeneous time-resolved fluorescence (HTRF) method in vitro.	Oleanolic Acid	27-41	kinase insert domain receptor	Homo sapiens	128-135	
31888388-1	2021	In this study, twenty-four oleanolic acid (OA) derivatives were rationally designed based on molecule docking studies and their VEGFR-2 inhibitory activities were tested by Homogeneous time-resolved fluorescence (HTRF) method in vitro.	Oleanolic Acid	43-45	kinase insert domain receptor	Homo sapiens	128-135	
31888388-4	2021	The results indicated that insertion of phenylurea group with a linker at position C-28 of OA can increase the activity against VEGFR-2 significantly.	Oleanolic Acid	91-93	kinase insert domain receptor	Homo sapiens	128-135	
29065844-0	2018	Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.	Oleanolic Acid	0-14	kinase insert domain receptor	Homo sapiens	71-77